Search results for: cancer prevention agent

SOURCES SOUGHT (Small Business): On behalf of the National Cancer Institute (NCI), Division of Cancer Prevention (DCP)TITLE: “Regulatory Support for Cancer Prevention Agent Development”INTRODUCTIONThe National Institutes of Health (NIH) National Cancer Institute (NCI), Division of Cancer Prevention (DCP) is issuing this Sources Sought as a means of conducting market research to invite participation from all Small Business concerns that are engaged

of current topics, progress, and opportunities in cancer preventive agent development research.Background:The National Cancer Institute (NCI), Division of Cancer Prevention (DCP) has over 40 active clinical trials, 15 trials in development and is the sponsor for approximately 35 INDs (Investigational New Drug Applications).

REGULATORY SUPPORT FOR CANCER PREVENTION AGENT DEVELOPMENT Solicitation ID/Procurement Identifier: N02CN7500810 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2023

CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM Solicitation ID/Procurement Identifier: N01CN0501469 Ultimate Completion Date: Fri Sep 22 17:00:00 GMT 2023

CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM Solicitation ID/Procurement Identifier: TORFP NN2019 Ultimate Completion Date: Fri Sep 22 17:00:00 GMT 2023

The purpose of this contract is to provide regulatory services and technical support to the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI). NCI and DCP has a recurring requirement for regulatory services and technical support to gather and summarize a vast amount of preclinical and clinical data associated with potential cancer preventive agents.

The purpose of this contract is to provide regulatory services and technical support to the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI). NCI and DCP has a recurring requirement for regulatory services and technical support to gather and summarize a vast amount of preclinical and clinical data associated with potential cancer preventive agents.